摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(rac)-2-(4-{1-[4-(2,6-difluoro-phenyl)-5-oxo-1-(4-trifluoromethyl-phenyl)-4,5-dihydro-1H-[1,2,4]triazol-3-yl]-5,5,5-trifluoro-pentyloxy}-2-methyl-phenoxy)-2-methyl-propionic acid | 1050441-48-9

中文名称
——
中文别名
——
英文名称
(rac)-2-(4-{1-[4-(2,6-difluoro-phenyl)-5-oxo-1-(4-trifluoromethyl-phenyl)-4,5-dihydro-1H-[1,2,4]triazol-3-yl]-5,5,5-trifluoro-pentyloxy}-2-methyl-phenoxy)-2-methyl-propionic acid
英文别名
2-[4-[1-[4-(2,6-Difluorophenyl)-5-oxo-1-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-3-yl]-5,5,5-trifluoropentoxy]-2-methylphenoxy]-2-methylpropanoic acid
(rac)-2-(4-{1-[4-(2,6-difluoro-phenyl)-5-oxo-1-(4-trifluoromethyl-phenyl)-4,5-dihydro-1H-[1,2,4]triazol-3-yl]-5,5,5-trifluoro-pentyloxy}-2-methyl-phenoxy)-2-methyl-propionic acid化学式
CAS
1050441-48-9
化学式
C31H27F8N3O5
mdl
——
分子量
673.56
InChiKey
WWHZBBBCMBVGBB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.2
  • 重原子数:
    47
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    91.7
  • 氢给体数:
    1
  • 氢受体数:
    14

文献信息

  • PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS
    申请人:Pfeifer Lance Allen
    公开号:US20100099725A1
    公开(公告)日:2010-04-22
    The present invention is directed to compounds of the structural Formula: wherein: R 1 is H or —C 1 -C 3 alkyl; R 2 is selected from the group consisting of —H, —C 1 -C 4 alkyl, —C 1 -C 3 alkyl-CF 3 , phenyl, and pyridinyl; and R 3 is selected from the group consisting of —H, —C 1 -C 4 alkyl, —C 1 -C 3 alkyl-O—CH 3 , —CH 2 -cyclopropyl, CH 2 —C═CH 2 , —CH 2 CH 2 -(2-F-phenyl), and phenyl substituted with from 1 to 2 fluorines; provided that when R 1 and R 2 are each H, then R 3 is selected from the group consisting of —C 1 -C 4 alkyl, —C 1 -C 3 alkyl-O—CH 3 , —CH 2 -cyclopropyl, —CH 2 —C═CH 2 , —CH 2 CH 2 -(2-F-phenyl), and phenyl substituted with from 1 to 2 fluorines; or stereoisomers and pharmaceutically acceptable salts thereof.
    本发明涉及结构式的化合物:其中:R1为H或-C1-C3烷基;R2选择自-H、-C1-C4烷基、-C1-C3烷基-CF3、苯基和吡啶基的组合;R3选择自-H、-C1-C4烷基、-C1-C3烷基-O-CH3、-CH2-环丙基、 -C═ 、- -(2-F-苯基)和1至2个原子取代的苯基;但当R1和R2都为H时,R3选择自-C1-C4烷基、-C1-C3烷基-O- 、- -环丙基、- -C═ 、- -(2-F-苯基)和1至2个原子取代的苯基;或其立体异构体和药学上可接受的盐。
查看更多